StoryPeople
Hal Barron leaves GSK to become Altos Labs CEO
Altos LabsCellular rejuvenation programming
Hal Barron, previously GSK's chief scientific officer, took over as Altos Labs CEO on August 1, 2022, as scheduled when the $3 billion rejuvenation company launched in January 2022. Founders Rick Klausner and Hans Bishop remained as chief scientist and president.
- Hal Barron transitioned from GSK Chief Scientific Officer to Altos Labs CEO as planned.
- Rick Klausner remains Chief Scientist; Hans Bishop continues as President.
- Altos launched January 2022 with $3 billion committed to cellular rejuvenation programming.
- Altos established three geographic hubs: San Francisco Bay Area, San Diego, and Cambridge, UK.